Project Disconnect


The people in the practice are ok. The problem is Bharat. He is a narcissist and a deplorable leader and human being and unfortunately his stench and crazy misdirections rubs off on the rest of them. That's why anyone worth anything has already left that team and will continue to do so. The only useless one is Greg Miller, a reputation he had long before joining the practice. JC just needs to admit he made a horrible mistake hiring Bharat and cut him loose. Bharat's abusive reign of creating a hostile work environment must end.
 
the entire ExCom has no credibility when you keep an Ismail or Bharat on staff. Zero.

Can’t agree more. It took insider trading to get rid of Ismail. What’s it going to take with Bharat? Another death? He spreads nothing but misery. You’re right. JC and Excom have zero credibility. Can’t listen to one more word our of their mouths.
 
Does anyone know anyone about Dr. Dhaval Patel? https://www.youtube.com/watch?v=44t00Ih0Vtc

He's now head of New Meds at UCB. He hasn't revealed much about himself yet. What was he like in Novartis?
Great leader, down to earth, pragmatic and competent. Hope JC will listen to him and leave him range of motion...
He will need to nuke and rebuild his organization starting from the leadership team as first move. Celltech is over
 
Another great move by Bharat and James Z. They just replaced the previous head of Access to New Meds with a 34 year old with less than 3 years experience in the pharma industry. Bharat, any more junior and under-qualified people or people with no pharma/medical background to fill in senior positions?
 
Bharat needs to go next, then all of his marketing practice. Not one person delivers any value in that practice

Remember, its all about "making a start", "pilots", "learning experiences".....and remember again, it's about helpfulness and generosity to overpay r*****s and then reward them for their mistakes.

Well done UCB. Now hopefully Alex Moscho who is the new Head of Strategy will clean shop - oh no, just remembered, he has Luc Uylenbroeck reporting to him........
 
Great leader, down to earth, pragmatic and competent. Hope JC will listen to him and leave him range of motion...
He will need to nuke and rebuild his organization starting from the leadership team as first move. Celltech is over

Ha! Ismail Kola tried to do that, and they eventually got rid of him. JC is stuck in the 1980s, we need a new CEO!!!!!
 
This company needs leadership - not primary care micro managers that try to manager by metrics - A speciaity company provides leadership by driving business instead of by metrics - when a Sales organization allows persons (MC and others) to dictate to the field how they should be driving business, then there is a major problem -
 
Oh really now? Just watch me post those all again.

The posts were absolutely spot on - best thing about them was that they were so funny too!

I can’t wait for him/her to start posting again.

Btw, heard rumours that Bharat’s final count down could be January 2018. Is UCB going to have a party just like EMD Serono did AFTER Bharat left?
 
The posts were absolutely spot on - best thing about them was that they were so funny too!

I can’t wait for him/her to start posting again.

Btw, heard rumours that Bharat’s final count down could be January 2018. Is UCB going to have a party just like EMD Serono did AFTER Bharat left?

yes, but Bharat fired Eddie Chan out of the blue in February 2018 as a desperate attempt to extend his miserable survival for another 6 months or year. JC may then give Bharat a low value role such as,

"Head of Corporate Fashion"
"Head of Design Catering at UCB training courses"
"Head of MeMeMe Academy"
"Head of Ice Cream Cones on a hot thursday in Brussels"
"Head of Red Bull consumption analytics at UCB"
 
Bharat's ex boss at Merck Serono was the head of the US and then became the CEO. No prizes for guessing who was doing all the great work for him.....read below - but a summary for those who don't have the attention span to read any document more than 200 words (that's UCB for you - what? what was that? sorry, I was looking at text message, pinging someone on skype and reading the next juicy low-value announcement on UCB plaza:

"accused of using an M.S. charity as a "money laundering thing" that funneled kickbacks to doctors who prescribed a lot of its M.S. drug, Rebif.

Another "meaningful way" that Firouz tripled his revenues was by illegally promoting human growth hormone to AIDS patients for unapproved "off-label" uses. In 2005, the company paid $705 million to make the case go away."


CBS News 2011
https://www.cbsnews.com/news/why-an-ms-drugmaker-took-2-weeks-to-disclose-its-ceo-had-quit/
Multiple sclerosis drugmaker EMD Serono has a new CEO, James Hoyes, which isn't news until you ask what happened to the old CEO. Former CEO Fereydoun Firouz resigned sometime before May 3, but the company didn't tell anyone outside the building until it published this May 20 press release.

It was almost as if Serono was unprepared when Firouz suddenly "independently decided to pursue other professional opportunities," as the statement put it. The company didn't quote Firouz even though he had been with the company for two decades.

In an unfortunate coincidence, Firouz's departure came 24 hours before Serono agreed to pay a $44 million settlement in a case in which it had been accused of using an M.S. charity as a "money laundering thing" that funneled kickbacks to doctors who prescribed a lot of its M.S. drug, Rebif. The charity then sent cease-and-desist letters to an M.S. activist who used her Facebook page to highlight the allegations. Firouz was not personally accused of any wrongdoing.

Feyrouz became CEO in 2003. Serono said:

During his tenure as President and CEO of EMD Serono, Mr. Firouz tripled the revenues and capabilities of the US organization, instilling pride, integrity and purpose amongst the employee base with a focus on advancing science and medicine, impacting the health of patients, being a leader and contributing to society in a meaningful way. Another "meaningful way" that Firouz tripled his revenues was by illegally promoting human growth hormone to AIDS patients for unapproved "off-label" uses. In 2005, the company paid $705 million to make the case go away. That settlement excluded Serono from receiving revenue from Medicare and Medicaid, and put the company under a five-year corporate integrity agreement. The more recent "money laundering thing" extended the CIA another three years.
Perhaps Hoyes will have more luck during his tenure. He has already promised to be more transparent about Serono's payments to doctors.
 


Write your reply...